Carlsmed, Inc.
Carlsmed (Nasdaq: CARL) is a commercial-stage medical technology company that develops AI-enabled personalized solutions for spine fusion surgery. Its aprevo Technology Platform uses diagnostic imaging and algorithms to create patient-specific surgical plans and interbody implants, along with single-use surgical… From the company’s description.
In fiscal 2025, Carlsmed, Inc. reported revenue of $50.51M and a net loss of $29.63M. Its operating margin was −60.5%, and operations used $28.98M in cash. Over the twelve months to Jun 30, 2026, revenue was $63.30M.
Dotted labels explain each measure. is shown separately from the annual figures.
What Carlsmed, Inc. does
In the company’s own words
Carlsmed (Nasdaq: CARL) is a commercial-stage medical technology company that develops AI-enabled personalized solutions for spine fusion surgery. Its aprevo Technology Platform uses diagnostic imaging and algorithms to create patient-specific surgical plans and interbody implants, along with single-use surgical instruments; it also incorporates post-operative data into planning. The platform is marketed for lumbar and cervical procedures, including treatment of degenerative disc disease and adult spinal deformity. Carlsmed sells to hospitals and ambulatory surgical centers through a direct sales team and independent sales agents, with surgeons as platform users. Its cervical offerings include aprevo interbody implants and the corra Cervical Plating System. The company operates as a single business focused on the aprevo platform, rather than reporting multiple business segments. For the year ended December 31, 2025, Carlsmed generated $50.5 million in revenue; as of that date, 253 surgeons had completed at least one procedure using the platform. Its website is www.carlsmed.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- CARLSBAD, CA
- Fiscal year end
- December
- CIK
- 1794546
- SIC
- 3841
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Carlsmed, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Carlsmed, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Carlsmed, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Carlsmed, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Carlsmed, Inc.'s last four quarterly filings that the numbers alone won't show?”